Viewing StudyNCT01597258



Ignite Creation Date: 2024-05-06 @ 12:31 AM
Last Modification Date: 2024-10-26 @ 10:51 AM
Study NCT ID: NCT01597258
Status: COMPLETED
Last Update Posted: 2019-09-13
First Post: 2012-05-10

Brief Title: Safety And Efficacy Of Crizotinib Regulatory Post Marketing Commitment Plan
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer
Keywords:
Name View
ALK-positive unresectable advanced andor recurrent non-small cell lung cancer View
Safety View
All cases surveillance in Japan View